Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Luspatercept

Review the clinical trials studying luspatercept on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-6 of 6

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
Status: Active
Location: 15 locations
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Status: Active
Location: 3 locations
Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes or Myeloproliferative Neoplasms
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Luspatercept and Lenalidomide for the Treatment of Anemia in Patients with Myelodysplastic Syndromes
Status: Temporarily Closed to Accrual
Location: 5 locations
Luspatercept for Reducing the Number of Blood Transfusions in Patients with Lower Risk Myelodysplastic Syndromes
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas